MSR1 and neoplasm: In contrast, the tumor tissue after a treatment with the anti-PD1 antibody showed strong stainings for CD3-, CD4-, and CD8-positive cells (as illustrated in Figure 2B, third column) and unaltered strong CD204 positivity (as illustrated in Figure 2C, third column).